Loading company…
Riskpilot
← Back to search
Sign in
Get full access
ISOVOX MedTech AB
AB
Dissolved
Org 5591731343
Manufacture of medical and dental instruments and supplies · NACE 3250
Est. 2018
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2022
SEK 121K
-76% vs 2021
EBITDA margin
39.2%
-80% vs 2021
Equity ratio
90.1%
Financial strength
Net profit 2022
SEK 47K
-80% vs 2021
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
-1M
2019
0M
+100%
2020
0M
0%
2021
0M
0%
2022
Key figures
Annual report 2022
Revenue
SEK 121K
-76%
EBITDA
SEK 47K
-80%
Net profit
SEK 47K
-80%
Total assets
SEK 619K
+17%
Equity
SEK 558K
+9%
Employees
1
—
Company information
Legal name
ISOVOX MedTech AB
Org number
5591731343
Legal form
Aktiebolag
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
26 september 2018
Share capital
SEK 53 200
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av Mayson, Philip Daniel Tord
Company purpose
Bolaget skall bedriva tillverkning och försäljning av mobila röst-bås för medicintekniskt bruk samt bedriva annan därmed förenlig verksamhet.
Contact
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Manufacture of medical and dental instruments and supplies
Companies in
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2019
0M
2020
1M
2021
0M
2022
EBITDA
SEK millions
0M
0M
1M
1M
1M
-1M
2019
0M
2020
0M
2021
0M
2022
Income statement
SEK thousands
Item
2019
2020
2021
2022
Revenue
14
4
514
121
Staff expenses
—
—
—
−36
EBITDA
−604
−175
240
47
Depreciation & amort.
−0
−0
−0
—
EBIT
−604
−175
240
47
Net financials
—
—
—
0
Profit before tax
−604
−175
240
47
Tax
−0
−0
−0
—
Net profit
−604
−175
240
47
Balance sheet
SEK thousands
Item
2019
2020
2021
2022
Total assets
511
287
531
619
Equity
446
271
510
558
Long-term debt
0
0
0
—
Short-term debt
65
17
20
61
Total debt
65
17
20
61
Financial ratios
5-year trend
EBITDA margin
39.2%
This company
15.8%
Market median
+148% vs market
2019
2022
Equity ratio
90.1%
This company
38.2%
Market median
+136% vs market
2019
2022
Return on equity
8.5%
This company
18.4%
Market median
-54% vs market
2019
2022
Net profit margin
39.2%
This company
8.1%
Market median
+384% vs market
2019
2022
Asset turnover
0.20×
This company
1.12×
Market median
-82% vs market
2019
2022
Debt / equity
0.11×
This company
0.62×
Market median
+82% vs market
2019
2022
Annual reports & filings
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via Bolagsverket / SCB · Period 2018-09-01 – 2019-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
PD
Philip Daniel Tord Mayson
Board of Directors
2022
JM
Julia May Nicole Juliette Mayson
Deputy Board Member
2022
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
ISOVOX AB
Company
94%
94%
0001
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
ISOVOX AB
ISOVOX MedTech AB
(this company)
Board network connections
Board members of ISOVOX MedTech AB also hold positions in
0
other companies.
Person
Role here
Other companies
Philip Daniel Tord Mayson
Board of Directors
0 companies
Julia May Nicole Juliette Mayson
Deputy Board Member
0 companies